NCT00214097View on ClinicalTrials.gov

Phase I/II Hypofractionated Radiotherapy for Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

347

Participants

Timeline

Start Date

October 14, 2002

Primary Completion Date

August 21, 2017

Study Completion Date

August 21, 2017

Conditions
Prostate Cancer
Interventions
RADIATION

Radiotherapy

Daily radiation to prescribed dose

Trial Locations (1)

53792

University of Wisconsin Hospital and Clinics, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT00214097 - Phase I/II Hypofractionated Radiotherapy for Prostate Cancer | Biotech Hunter | Biotech Hunter